NanoRepro AG (ETR:NN6)
Germany · Delayed Price · Currency is EUR 1.575
+0.005 (0.32%)
Nov 4, 2026, 5:35 PM CET
NanoRepro AG Company Description
NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally.
The company offers products in the areas of family planning, preventive healthcare, intolerances, and infectious diseases.
It also develops and commercializes immunochromatographic lateral flow tests; and point of care testing for hospitals and medical practices.
NanoRepro AG was incorporated in 2007 and is headquartered in Marburg, Germany.
NanoRepro AG
| Country | Germany |
| Founded | 2007 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 22 |
| CEO | Lisa Jungst |
Contact Details
Address: Untergasse 8 Marburg, 35037 Germany | |
| Phone | 49 6421 951449 |
| Website | nanorepro.com |
Stock Details
| Ticker Symbol | NN6 |
| Exchange | Deutsche Börse Xetra |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | DE0006577109 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Lisa Jungst | President of the Management Board and Chief Executive Officer |
| Stefan Pieh | Chief Financial Officer |
| Mike Eckel | Member of Management Board |